Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455–3p/HDAC4
Hormone and Metabolic Research · 01.10.2023 · 55 (10) · 722-732
DOI: 10.1055/a-2125-7018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.10.2023. Verfasst von Shunxin Hao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Wuhan University of Science and Technology Hospital, Wuhan, China. Hauptthemen laut MEDLINE: MicroRNAs, Histone Deacetylases, Pancreatic Neoplasms, RNA, Circular. Die Arbeit nennt 56 Literaturangaben.
Abstract (Originalsprache)
Circular RNAs (circRNAs) frequently participate in pancreatic cancer (PC) progression. This study focuses on circ_0000106, a novel circRNA, and its potential function in PC development. Circ_00001106, miR-455–3p, and HDAC4 expression levels in PC were determined using qRT-PCR and immunoblotting. RNA immunoprecipitation and dual-luciferase reporter assays were performed to verify their binding interactions. Loss-of-function assays, including CCK-8, colony formation, and transwell assays, were used to estimate the proliferative and migratory properties of PC cells. A nude mouse model was constructed to assess the influence of circ_0000106 on tumor formation in vivo. A pronounced elevation of circ_0000106 and HDAC4 and a reduction of miR-455–3p in PC were observed. Circ_0000106 was prone to binding to miR-455–3p, and miR-455–3p further targeted HDAC4. Functionally, the proliferative and migratory properties of PC cells were dampened by the loss of circ_0000106 or HDAC4 and could be potentiated by miR-455–3p inhibition. Moreover, the knockdown of circ_0000106 delayed tumor growth in vivo. Additionally, the downregulation of miR-455–3p attenuated the repressive effects of circ_0000106 deficiency on PC cell migration and proliferation. Loss of HDAC4 exerted similar mitigative effects on miR-455–3p downregulation-stimulated PC cells. In conclusion, circ_0000106 promotes tumor migration and growth in PC by targeting the miR-455–3p/HDAC4 axis. These results suggest that the circ_0000106/miR-455–3p/HDAC4 network could be regarded as a latent target for PC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Wuhan University of Science and Technology Hospital, Wuhan, China.
Zitieren
APA
Hao, S., Yao, Z., & Liu, Y. (2023). Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455–3p/HDAC4. Hormone and Metabolic Research, 55(10), 722-732. https://doi.org/10.1055/a-2125-7018
Vancouver
Hao S, Yao Z, Liu Y. Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455–3p/HDAC4. Hormone and Metabolic Research. 2023;55(10):722-732. doi:10.1055/a-2125-7018
BibTeX
@article{Hao2023,
author = {Hao, Shunxin and Yao, Zhi and Liu, Yifeng},
title = {Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455–3p/HDAC4},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {10},
pages = {722--732},
doi = {10.1055/a-2125-7018}
}
EUVIMED